Skip to Content

Medications for Gastrointestinal Decontamination

What is Gastrointestinal Decontamination:  Gastrointestinal decontamination refers to the practice of removing an ingested toxin/poison from the GI tract in order to decrease its absorption.

Medications to treat Gastrointestinal Decontamination

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
polyethylene glycol 3350 with electrolytes C N 4 reviews
6.0

Generic name: polyethylene glycol 3350 with electrolytes systemic

Brand names:  PEG-3350 with Electolytes, NuLYTELY, GaviLyte-G, GaviLyte-N, GoLYTELY, MoviPrep, Colyte, Suclear, TriLyte, GaviLyte-C

Drug class: laxatives

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, Prescribing Information

 
PEG-3350 with Electolytes C N 1 review
10

Generic name: polyethylene glycol 3350 with electrolytes systemic

Drug class: laxatives

For consumers: dosage, interactions, side effects

 
NuLYTELY C N Add review Rate

Generic name: polyethylene glycol 3350 with electrolytes systemic

Drug class: laxatives

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
GaviLyte-G C N Add review Rate

Generic name: polyethylene glycol 3350 with electrolytes systemic

Drug class: laxatives

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
GaviLyte-N C N Add review Rate

Generic name: polyethylene glycol 3350 with electrolytes systemic

Drug class: laxatives

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
GoLYTELY C N Add review Rate

Generic name: polyethylene glycol 3350 with electrolytes systemic

Drug class: laxatives

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
MoviPrep C N 3 reviews
4.0

Generic name: polyethylene glycol 3350 with electrolytes systemic

Drug class: laxatives

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Colyte C N Add review Rate

Generic name: polyethylene glycol 3350 with electrolytes systemic

Drug class: laxatives

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Suclear C N Add review Rate

Generic name: polyethylene glycol 3350 with electrolytes systemic

Drug class: laxatives

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Actidose Plus Sorbitol N N Add review Rate

Generic name: charcoal / sorbitol systemic

Drug class: antidotes

For consumers: interactions, side effects

 
TriLyte C N Add review Rate

Generic name: polyethylene glycol 3350 with electrolytes systemic

Drug class: laxatives

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
GaviLyte-C C N Add review Rate

Generic name: polyethylene glycol 3350 with electrolytes systemic

Drug class: laxatives

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
charcoal / sorbitol N N Add review Rate

Generic name: charcoal / sorbitol systemic

Brand name:  Actidose Plus Sorbitol

Drug class: antidotes

For consumers: interactions, side effects

 

Topics under Gastrointestinal Decontamination

Alternative treatments for Gastrointestinal Decontamination

The following products are considered to be alternative treatments or natural remedies for Gastrointestinal Decontamination. Their efficacy may not have been scientifically tested to the same degree as the drugs listed in the table above. However there may be historical, cultural or anecdotal evidence linking their use to the treatment of Gastrointestinal Decontamination.

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hide